Medtronic (MDT) Gains But Lags Market: What You Should Know

Medtronic (MDT) ended the recent trading session at $82.90, demonstrating a +0.44% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1.81%. Elsewhere, the Dow gained 1.56%, while the tech-heavy Nasdaq added 2.06%.Shares of the medical device company have depreciated by 10.6% over the course of the past month, outperforming the Medical sector's loss of 12.01% and lagging the S&P 500's loss of 6.14%.The upcoming earnings release of Medtronic will be of great interest to investors. The company's earnings report is expected on May 21, 2025. It is anticipated that the company will report an EPS of $1.58, marking an 8.22% rise compared to the same quarter of the previous year. Meanwhile, the latest consensus estimate predicts the revenue to be $8.81 billion, indicating a 2.57% increase compared to the same quarter of the previous year.For the full year, the Zacks Consensus Estimates are projecting earnings of $5.46 per share and revenue of $33.48 billion, which would represent changes of +5% and +3.44%, respectively, from the prior year.Investors should also take note of any recent adjustments to analyst estimates for Medtronic. Recent revisions tend to reflect the latest near-term business trends. Hence, positive alterations in estimates signify analyst optimism regarding the company's business and profitability.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, there's been no change in the Zacks Consensus EPS estimate. Medtronic is currently a Zacks Rank #3 (Hold).In terms of valuation, Medtronic is presently being traded at a Forward P/E ratio of 15.13. This indicates a premium in contrast to its industry's Forward P/E of 14.73.One should further note that MDT currently holds a PEG ratio of 2.08. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. By the end of yesterday's trading, the Medical - Products industry had an average PEG ratio of 1.95.The Medical - Products industry is part of the Medical sector. This industry, currently bearing a Zacks Industry Rank of 177, finds itself in the bottom 29% echelons of all 250+ industries.The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com.Zacks Names #1 Semiconductor StockIt's only 1/9,000th the size of NVIDIA which skyrocketed more than +800% since we recommended it. NVIDIA is still strong, but our new top chip stock has much more room to boom.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $803 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Medtronic PLC (MDT): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks